NorthWest Biotherapeutics Inc (NWBO)

[MI Dendream]

FWIW to board members, since I know that I can be opinionated and extremely self-confident, I had the opportunity to do a gut check tonight and did.

I ran my own little informal pole of seasoned industry professionals at a dinner this evening. I asked a group whether they could give me any rationale for releasing Phase 3 trial data in a publication without first presenting the data at a congress…not one idea came forward.

Then, I gave a brief history of the situation here and asked if it now makes sense to do so. I will share one quote that summarizes the unanimous consensus.

“If you want to fight off a short attack, you want to maximize exposure not minimize it. In that situation, publishing without presenting makes no sense at all.”

It is not just me